You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression

 

Online download statistics by month:

Online download statistics by month: January 2021 to November 2024

AbstractFullPdf
Jan 2021690693199
Feb 202132332562
Mar 202113913938
Apr 202112312351
May 202110510549
Jun 202112812833
Jul 202113113154
Aug 202113913939
Sep 202110010047
Oct 202110410443
Nov 2021808028
Dec 2021878737
Jan 2022687044
Feb 2022424518
Mar 2022575726
Apr 2022899447
May 2022788444
Jun 202212012632
Jul 2022778533
Aug 2022889133
Sep 2022798051
Oct 2022798132
Nov 20228413039
Dec 2022707131
Jan 2023535318
Feb 2023838317
Mar 2023636613
Apr 2023474730
May 2023414527
Jun 2023424721
Jul 2023292920
Aug 2023343414
Sep 2023151612
Oct 2023373717
Nov 2023545520
Dec 2023494933
Jan 2024424328
Feb 2024292930
Mar 2024505032
Apr 2024454546
May 2024313430
Jun 2024444631
Jul 20245458129
Aug 2024313317
Sep 2024262681
Oct 2024515131
Nov 2024535437
Total408341981844